VANGUARD GROUP INC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPH and the CUSIP is 88165N204. A total of 26 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2020$175,000
+236.5%
69,402
+72.6%
0.00%
Q1 2020$52,000
-54.0%
40,2200.0%0.00%
Q4 2019$113,000
-80.1%
40,220
-62.4%
0.00%
Q3 2019$568,000106,8880.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2020
NameSharesValueWeighting ↓
CVI Holdings, LLC 208,074$524,0000.19%
ARMISTICE CAPITAL, LLC 1,419,507$3,577,0000.16%
Tekla Capital Management LLC 42,965$108,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 30,000$76,0000.00%
ACADIAN ASSET MANAGEMENT LLC 78,218$197,0000.00%
UBS Group AG 2,925$7,0000.00%
Sargent Bickham Lagudis LLC 1,000$3,0000.00%
Sowell Financial Services LLC 1$00.00%
OSAIC HOLDINGS, INC. 150$00.00%
DIMENSIONAL FUND ADVISORS LP 12,664$32,0000.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders